Vijayakumar said the market will be looking for growth stimulating measures and not market-related taxation reliefs like changes in the capital gains taxation.
22mon MSN
Sun Pharma reported a 15% YoY rise in Q3FY25 profit to Rs 2,903 crore, surpassing estimates. Revenue grew 10% to Rs 13,675.5 crore, driven by domestic and emerging markets. API sales rose 22%, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback